MIR3621

Across TCGA pan-cancer cohorts, MIR3621 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR3621 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR3621 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3621 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCS, KICH, and GBM are the cancer types where MIR3621 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.001	0.690	<.001	108	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
GBM	OS	Tertile	All	0.076	0.415	<.001	27	view →
COAD	DFS	Tertile	All	0.169	0.527	.009	24	view →
READ	OS	Tertile	II,III,IV	0.205	0.681	.016	18	view →
UCEC	DFS	Tertile	All	0.963	0.631	.027	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR3621–UCS (OS)

Open the UCS breakdown →